ArticleBiomedicines2025

Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate.

Marcin Bazylewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.